+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Growth Opportunities in Platform Technologies, Diagnostics, and Advanced Therapeutics

  • PDF Icon


  • 39 Pages
  • September 2021
  • Region: Global
  • Frost & Sullivan
  • ID: 5457745

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on advanced therapeutics development for neurological disorders, oncology, immunological diseases. Peptide-drug conjugates, targeted antibodies, gene therapy, and cell therapies have also been discussed in this edition. Protein bioprinting, fiber-based chromatography, and other disruptive technologies are also highlighted. A few innovations around diagnostics, personalized medicine development, and clinical decision support tools leveraging AI and ML are also featured.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Table of Contents

1. Innovations In Life Sciences, Health & Wellness

  • Fiber Based Single Use Chromatography to Enhance Downstream Processing
  • Ultrafast Purification Technology
  • Cytiva Lifesciences - Investor Dashboard
  • Precision Synthetic Biology Platform to Program Pluripotent Stem Cells
  • Cryopreserved Reprogrammed Cells
  • Bit Bio Limited - Investor Dashboard
  • Engineered Crispr-Based Therapeutics
  • AAV-Enabled Delivery Methods
  • Scribe Therapeutics - Investor Dashboard
  • Lion Technology, With Access, Activate, And Amplify Platforms for Cancer And Infectious Diseases
  • Lion-Based RNA Therapeutics Target Multiple Indications Including COVID-19
  • HDT Bio - Investor Dashboard
  • Synthetic Biology Enabled In Vitro Protein Printing
  • Nuclera’s Protein Bioprinter Nominates Best Protein Expression Conditions In A Day
  • Nuclera Nucleic - Investor Dashboard
  • Peptide-Drug Conjugate For Oncology And Beyond
  • Bicycle Therapeutics’ Peptide-Drug Conjugates Exhibit Additional Advantages Over Other Conjugates
  • Bicycle Therapeutics - Investor Dashboard
  • Codeevolver Platform For Directed Enzyme Evolution
  • Codeevolver Improves Enzyme’s Functionality By Orders Of Magnitude
  • Codexis - Investor Dashboard
  • Gene Therapy For Bladder Cancer
  • Precision Drug Development Platforms
  • Therapies For Refractory Chronic Cough
  • Targeted Antibody Therapy For Immunological Diseases
  • AI-Aided Single Cell Isolation For Translational Research
  • Patient-Centered Health Intelligence to Understand Diseases For Better Clinical Decisions

2. Key Contacts

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bicycle Therapeutics
  • Bit Bio Limited
  • Codexis
  • Cytiva Lifesciences
  • HDT Bio
  • Nuclera Nucleic
  • Scribe Therapeutics